Ultiva 1 mg, 2 mg, 5 mg powder for concentrate for solution for infusion
- Name:
Ultiva 1 mg, 2 mg, 5 mg powder for concentrate for solution for infusion
- Company:
Aspen
- Active Ingredients:
- Legal Category:
Product subject to medical prescription which may not be renewed (A)
Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 26/03/19
(Click to Download)XPIL
Package leaflet: Information for the patient
Package leaflet: Information for the patient
1. What Ultiva is and what it is used for
1. What Ultiva is and what it is used for
2. What you need to know before you are given Ultiva
2. What you need to know before you are given Ultiva
3. How Ultiva is given
3. How Ultiva is given
4. Possible side effects
4. Possible side effects
5. How to store Ultiva
5. How to store Ultiva
6. Contents of the pack and other information
6. Contents of the pack and other information
Aspen
Company Products
Items Per Page :
1 - 0 of 63 items.Total: Infinity pages
When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.
Updated on 26 March 2019 PIL
Reasons for updating
- Change to section 4 - how to report a side effect
- Change to section 6 - marketing authorisation holder
- Change to date of revision
Updated on 15 October 2018 PIL
Reasons for updating
- Change to section 2 - what you need to know - contraindications
- Change to section 4 - possible side effects
- Change to section 6 - what the product contains
- Change to section 6 - what the product looks like and pack contents
- Change to section 6 - date of revision
- Improved presentation of PIL
Updated on 12 September 2017 PIL
Reasons for updating
- New PIL for new product
Updated on 12 September 2017 PIL
Reasons for updating
- Change to section 6 - manufacturer
Updated on 15 August 2017 PIL
Reasons for updating
- Change to section 6 - marketing authorisation holder
- Change to section 6 - marketing authorisation number
- Change to section 6 - date of revision
Updated on 20 July 2015 PIL
Reasons for updating
- Change to date of revision
- Change to MA holder contact details
Updated on 15 July 2015 PIL
Reasons for updating
- Change to date of revision
- Change to MA holder contact details
Updated on 10 June 2015 PIL
Reasons for updating
- Change to warnings or special precautions for use
- Change to side-effects
- Change to date of revision
- Change to dosage and administration
- Correction of spelling/typing errors
- Improved electronic presentation
Updated on 30 January 2015 PIL
Reasons for updating
- Change to, or new use for medicine
- Change to date of revision
Updated on 10 November 2011 PIL
Reasons for updating
- Change due to user-testing of patient information
Updated on 15 July 2011 PIL
Reasons for updating
- Change to warnings or special precautions for use
- Correction of spelling/typing errors
Updated on 21 February 2011 PIL
Reasons for updating
- Change of active ingredient
- Change to warnings or special precautions for use
- Change to storage instructions
Updated on 4 August 2005 PIL
Reasons for updating
- New PIL for medicines.ie